子宮頸癌診斷檢測市場：依檢測類型、年齡層和地區分類

Cervical Cancer Diagnostic Tests Market, By Test Type, By Age Group, and By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，子宮頸癌診斷檢測市場規模將達到84.7億美元，2033年將達到131.6億美元。預計從2026年到2033年，該市場將以6.5%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	84.7億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.50%	2033年市場規模預測：	131.6億美元

子宮頸癌起源於子宮頸表面。當子宮頸細胞開始癌變時，就會發生這種情況。子宮頸癌主要分為兩大類：鱗狀細胞癌和腺癌。約80%至90%的子宮頸癌是鱗狀細胞癌，10%至20%是腺癌。 I期子宮頸癌的徵兆和症狀包括：水樣或血性陰道分泌物（可能量多或有異味）、性交後陰道出血、非月經或停經後陰道出血，以及月經量增加或經期延長。大多數子宮頸癌是由人類徵兆（HPV）引起的，HPV是一種性行為感染感染。 HPV透過性接觸（肛交、口交或陰道性交）傳播，並可導致癌症。大多數人一生中都會感染HPV病毒，但通常不會察覺，因為身體能夠抵抗感染。定期婦科檢查、子宮頸抹片檢查（子宮頸癌篩檢）、安全性行為是預防子宮頸癌最重要的措施。子宮頸癌的主要治療方法包括手術、放射線治療和化療。子宮頸癌的診斷方法包括子宮頸抹片檢查、陰道鏡檢查和子宮頸刮除術（ECC）。預計在預測期內，新興國家對子宮頸癌的認知不斷提高，以及子宮頸癌診斷研發投入的增加，將推動市場成長。

市場動態

在預測期內，由於子宮頸癌發生率上升、人類乳突病毒（HPV）感染人數眾多以及性活躍的青少年女性人數增加，全球子宮頸癌診斷檢測市場預計將會擴張。例如，根據世界衛生組織（WHO）2022年2月發布的報告，子宮頸癌是全球女性第四大常見癌症，2020年估計新增病例60.4萬例，死亡34.2萬例。 2020年全球約90%的新增病例和死亡病例發生在阿富汗、孟加拉、印度和中國等中低收入國家。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球子宮頸癌診斷測試市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球子宮頸癌診斷檢測市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球子宮頸癌診斷測試市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

Guided Therapeutics, Inc.
Abbott
Beckman Coulter, Inc.
BD（Becton, Dickinson and Company）
F.Hoffmann-La Roche Ltd
Bio Farma
Hologic, Inc.
Oncgnostics GmbH
AstraZeneca
MobileODT
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
DYSIS Medical Inc.
The Cooper Companies Inc.
Danaher
Quest Diagnostics
Arbor Vita Corporation
Zilico

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI3994

Cervical Cancer Diagnostic Tests Market is estimated to be valued at USD 8.47 Bn in 2026 and is expected to reach USD 13.16 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.47 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.50%	2033 Value Projection:	USD 13.16 Bn

Cervical cancer, or cancer of the cervix, begins on the surface of your cervix. It happens when the cells on your cervix begin to change to precancerous cells. There are two main types of cancer of the cervix: squamous cell carcinomas and adenocarcinomas. About 80% to 90% of cervical cancers are squamous cell carcinomas, while 10% to 20% are adenocarcinomas. Watery or bloody vaginal discharge that may be heavy and can have a foul odor, vaginal bleeding after intercourse, between menstrual periods or after menopause and menstrual periods may be heavier and last longer than normal are some sign and symptoms of stage 1 cervical cancer. Most cervical cancers are caused by the virus HPV, a sexually transmitted infection. Human papillomavirus (HPV) spreads through sexual contact (anal, oral or vaginal) and can lead to cancer. Most people will get HPV at some point in their lives and not realize it because their bodies fight the infection. Receiving regular gynecological exams, getting Pap tests and practicing safe sex are the most important steps that you can take toward the prevention of cervical cancer. Surgery, radiation and chemotherapy are the main treatments for cervical cancer. Pap smear, colposcopy, and endocervical curettage (ECC) procedures are performed for the diagnosis of cervical cancer. Increasing awareness regarding cervical cancer in emerging economies and increasing funding for research and development in diagnosis of cervical cancer are expected to drive growth of the market during the forecast period.

Market Dynamics

Over the projected period, the global market for cervical cancer diagnostic tests is anticipated to increase due to the rising incidence of the disease, the high frequency of patients infected with the human papillomavirus (HPV), and the rising number of teenage sex experiences. For instance, in February 2022, according to the World Health Organization (WHO), Cervical cancer is the fourth most common cancer among women globally, with an estimated 604 000 new cases and 342 000 deaths in 2020. About 90% of the new cases and deaths worldwide in 2020 occurred in low- and middle-income countries such as Afghanistan, Bangladesh, India, China, etc.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cervical cancer diagnostic tests market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Guided Therapeutics, Inc., Abbott, Beckman Coulter, Inc., BD (Becton, Dickinson and Company), F. Hoffmann-La Roche Ltd, Bio Farma, Hologic, Inc., Oncgnostics GmbH, AstraZeneca, MobileODT, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., DYSIS Medical Inc., The Cooper Companies Inc., Danaher, Quest Diagnostics, Arbor Vita Corporation, and Zilico.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cervical cancer diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical cancer diagnostic tests market

Detailed Segmentation:

Global Cervical Cancer Diagnostic Tests Market, By Test Type (Revenue, USD Bn, 2021 - 2033)
Pap Smear Test
Colposcopy Test
Endocervical curettage Test
HPV Test
Global Cervical Cancer Diagnostic Tests Market, By Age Group:
Age 20-40
Age above 40
Global Cervical Cancer Diagnostic Tests Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Guided Therapeutics, Inc
Abbott
Beckman Coulter, Inc.
BD (Becton, Dickinson and Company)
Hoffmann-La Roche Ltd
Bio Farma
FinVector Vision Therapies
Hologic, Inc.
Oncgnostics GmbH
AstraZeneca
MobileODT
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
DYSIS Medical Inc.
The Cooper Companies Inc.
Danaher
Quest Diagnostics
Arbor Vita Corporation
Zilico

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Age Group
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Regulatory Guideline and Compliances
- Epidemiology
- Pricing Analysis
- Key Developments
- PEST Analysis
- PORTER's Analysis

4. Global Cervical Cancer Diagnostic Tests Market, By Test Type, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Pap Smear Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Colposcopy Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Endocervical curettage Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
HPV Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Cervical Cancer Diagnostic Tests Market, By Age Group, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segments Trends
Age 20-40
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Age above 40
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Global Cervical Cancer Diagnostic Tests Market, By Region, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Guided Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BD (Becton, Dickinson and Company)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
F.Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio Farma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Oncgnostics GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
MobileODT
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
DYSIS Medical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
The Cooper Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Danaher
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Arbor Vita Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zilico
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies